Abstract
Sigara kullanımı, kalp ve damar hastalıkları, kanserler ve solunum yolu hastalıklarına yol açan, önlenebilir ölüm ve sakatlık nedenlerinin başında yer almaktadır. Bupropion HCL bir antidepresan olup sigara içme isteğini ve yoksunluk yakınmalarının şiddetini azaltmaktadır. En yaygın yan etkisi; ağız kuruluğu, uykusuzluk, uyku bölünmeleri, deride kızarıklık ve kaşıntı olup alerjik reaksiyon riski 1/1000-10000'dir. Sigara bırakmada Bupropion HCL ile tedavi olan hastaların tedaviyi yarım bırakma nedenlerinden en sık olumsuz etki tremor ve döküntü olarak bildirilmiştir. Bu makalemizde, hastalarımıza verdiğimiz sağlık hizmetlerinde basit öykü alma ve fizik muayenenin hastalarımız açısından ne kadar önemli olduğu vurgulanmak istenmiştir.
Keywords
References
- 1. Holm KJ, Spencer CM. Bupropion: A review of its use in the management of smoking cessation. Drugs 2000; 59(4): 1007-24.
- 2. I.Campbell. Nicotine replacement therapy in smoking cessation. Thorax 2003; 58(6): 464-65.
- 3. Dale LC, Ebbert JO, Hays JT, Hurt RD. Treatment of nicotine dependence. Mayo Clin Proc 2000;75(12):1311-16.
- 4. Roddy E. Bupropion and other non nicotine pharmacotherapies. BMJ 2004; 28;328(7438):509-11.
- 5. Rennard SI, Daughton DM. Smoking cessation. Chest 2000; 117(5 Suppl 2):360S-64S.
- 6. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000; 55(12): 987-99.
- 7. Kotz D. Implementation of a new 'opt-out' default for tobacco treatment is urgently needed, but requires free access to evidence-based treatments. Addiction 2015;110(3):387-88.
- 8. Yorgancıoğlı A, Esen A. Sigara bağımlılığı ve hekimler. Toraks Dergisi 2000;1:90-95.
- 9. Faseru B, Turner M, Casey G, Ruder C, Befort CA, Ellerbeck EF, et al. Evaluation of a hospital-based tobacco treatment service: outcomes and lessons learned. J Hosp Med. 2011;6(4):211-8.
- 10. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146. doi: 10.1002/14651858.CD000146.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD000146.
- 11. Ferry LH. Non-nicotine pharmacotherapy for smoking cessation. Prim Care. 1999;26(3):653-69.
- 12. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation.N Engl J Med. 1997 23;337(17):1195-202.
- 13. Kutlu R , Karademirci MM, KT . Sigara bırakma tedavisi sırasında Bupropion Hcl’e bağlı gelişen Serum Hastalığı benzeri reaksiyon: Olgu Sunumu. Türk Aile Hek Derg 2017; 21 (1): 44-48.
- 14. Polat M, Uzun Ö, Örs I, Boran Ç. Pityriasis rosea-like drug eruption due to bupropion: a case report. Hum Exp Toxicol 2014 :33(12):1294-1296.
- 15. Erdem R, Rahman, S, Avcı L, Demirel B, Köseoğlu S, Fırat G ve ark. Hasta memnuniyetinin hasta bağlılığı üzerine etkisi. Erciyes Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi 2008;31:95-110.
Abstract
Smoking leads to
cardiovascular diseases, cancers, and respiratory tract diseases. Also, smoking
is at the center of the causes of preventable death and disability. Bupropion
HCL is an antidepressant and reduces the likelihood of smoking and the intensity
of withdrawal complaints. The most common side effect is; mouth dryness,
insomnia, sleep divisions, roseola, and itching, and the risk of allergic
reactions is 1 / 1000-10000. In patients treated with bupropion HCL, the most
common side effect causing treatment discontinuation was reported as tremor and
rash. In this article, it is aimed to emphasize how important it is to get a
simple history and physical examination in terms of our patients in our health
services.
Keywords
References
- 1. Holm KJ, Spencer CM. Bupropion: A review of its use in the management of smoking cessation. Drugs 2000; 59(4): 1007-24.
- 2. I.Campbell. Nicotine replacement therapy in smoking cessation. Thorax 2003; 58(6): 464-65.
- 3. Dale LC, Ebbert JO, Hays JT, Hurt RD. Treatment of nicotine dependence. Mayo Clin Proc 2000;75(12):1311-16.
- 4. Roddy E. Bupropion and other non nicotine pharmacotherapies. BMJ 2004; 28;328(7438):509-11.
- 5. Rennard SI, Daughton DM. Smoking cessation. Chest 2000; 117(5 Suppl 2):360S-64S.
- 6. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000; 55(12): 987-99.
- 7. Kotz D. Implementation of a new 'opt-out' default for tobacco treatment is urgently needed, but requires free access to evidence-based treatments. Addiction 2015;110(3):387-88.
- 8. Yorgancıoğlı A, Esen A. Sigara bağımlılığı ve hekimler. Toraks Dergisi 2000;1:90-95.
- 9. Faseru B, Turner M, Casey G, Ruder C, Befort CA, Ellerbeck EF, et al. Evaluation of a hospital-based tobacco treatment service: outcomes and lessons learned. J Hosp Med. 2011;6(4):211-8.
- 10. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146. doi: 10.1002/14651858.CD000146.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD000146.
- 11. Ferry LH. Non-nicotine pharmacotherapy for smoking cessation. Prim Care. 1999;26(3):653-69.
- 12. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation.N Engl J Med. 1997 23;337(17):1195-202.
- 13. Kutlu R , Karademirci MM, KT . Sigara bırakma tedavisi sırasında Bupropion Hcl’e bağlı gelişen Serum Hastalığı benzeri reaksiyon: Olgu Sunumu. Türk Aile Hek Derg 2017; 21 (1): 44-48.
- 14. Polat M, Uzun Ö, Örs I, Boran Ç. Pityriasis rosea-like drug eruption due to bupropion: a case report. Hum Exp Toxicol 2014 :33(12):1294-1296.
- 15. Erdem R, Rahman, S, Avcı L, Demirel B, Köseoğlu S, Fırat G ve ark. Hasta memnuniyetinin hasta bağlılığı üzerine etkisi. Erciyes Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi 2008;31:95-110.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Case Report |
| Authors | |
| Publication Date | March 19, 2018 |
| Submission Date | September 13, 2017 |
| Published in Issue | Year 2018 Volume: 12 Issue: 1 |
English or Turkish manuscripts from authors with new knowledge to contribute to understanding and improving health and primary care are welcome.